Oscar Health (OSCR) Stock: Buy, Sell, or Hold?
OSCR - Oscar Health, Inc.
$30.94
1.04 (3.48%)
â˛
5d:
+4.53%
30d:
+2.01%
90d:
-1.59%
WAIT
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Get Alerted When OSCR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: OSCR is fairly priced but lacks strong directional signals. At -1.3% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: OSCR is fairly priced but lacks strong directional signals. At -1.3% expected growth, valuation appears fair. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$48.63
Based on 8.6% avg growth
INTRINSIC VALUE TODAY
$30.20
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 14.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OSCR is currently trading at $30.94, which is considered fair relative to its 30-day fair value range of $29.96 to $32.39. The stock's valuation (Forward PE: 14.3) is in line with its historical norms (14.9). Remarkably, the market is currently pricing in an annual earnings decline of 1.3% over the next few years. This pessimistic expectation contrasts with the company's recent 125.6% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, OSCR is in a strong uptrend. Immediate support is located at $28.30, while resistance sits at $32.16. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: OSCR scores 61/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $35.40 (+14.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OSCR is in a strong uptrend. Immediate support is located at $28.30, while resistance sits at $32.16. The stock is showing strong short-term momentum, up 3.5% recently.
Market Sentiment: OSCR scores 61/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $35.40 (+14.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$29.96 -
$32.39
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
85.7%
Protect Your Profits
Holding OSCR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (61/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.5%)
- BULLISH: Trading below Wall St target ($35.40)
- WARNING: Composite score 51/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$29.96 -
$32.39
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$28.30
Resistance Level
$32.16
Current Trend
Strong Uptrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.29
Wall Street Target
$35.40
(+14.4%)
Revenue Growth (YoY)
70.4%
Earnings Growth (YoY)
125.6%
Profit Margin
3.6%
Valuation Discount vs History
-1.3% cheaper
PE vs Historical
14.3 vs 14.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.3%
(market-implied from PE analysis)
1-Year Target
$30.54
(-1%)
2-Year Target
$30.14
(-3%)
3-Year Target
$29.75
(-4%)
3-Yr Target (if PE normalizes)
(PE: 14â15)
$31.02
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.4, Growth: 13.2%)
$64.09
(+107%)
Base:
(SPY PE: 14.3, Growth: 13.2%)
$44.89
(+45%)
Bear:
(PE: 12.1, Growth: 13.2%)
$38.15
(+23%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (24x PE), but valuation improves significantly next year (14x PE) as earnings recover.
Trailing PE: 23.73 | Current EPS (TTM): $1.26
Bull Case
$56.53
(+83%)
Analyst growth 71.9%, PE expands to 26.1
Base Case
$51.39
(+66%)
Market implied 71.9%, PE stable at 23.7
Bear Case
$20.33
(-34%)
Severe decline -20.0%, PE contracts to 20.2
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.3 to 14.9
Stabilization Target:
$32.27
(+4.3%)
PE Expansion Potential:
+4.3%
Share & Embed Analysis
Last updated: October 04, 2026 4:13 AM ET
Data refreshes hourly during market hours. Next update: 5:13 AM
Data refreshes hourly during market hours. Next update: 5:13 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OSCR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Healthcare Plans Stocks
Top-rated stocks in Healthcare Plans by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CVS
CVS Health Corp |
STRONG BUY
28 analysts |
$116 | 66 BUY |
|
UNH
UnitedHealth Group IncorâĻ |
STRONG BUY
27 analysts |
$482 | 56 HOLD |
|
CI
Cigna Corp |
STRONG BUY
25 analysts |
$342 | 51 HOLD |
|
ELV
Elevance Health Inc |
STRONG BUY
22 analysts |
$451 | 45 HOLD |
|
HUM
Humana Inc |
HOLD
26 analysts |
$424 | 65 BUY |
Advanced OSCR Option Strategies
Professional options setups generated by AI based on today's OSCR price and gamma walls.
